Triple Jump News
2 articles
growth-positive
Medtronic in talks to buy Israeli co Triple Jump for $300m
Medtronic plans to acquire Triple Jump, an Israeli insulin pump patch developer, at a company valuation of $300 million. Triple Jumps insulin pump patch will be integrated into Medtronics artificial pancreas system to enhance its pumping capabilities. The patch is designed to be placed on the patients body and has mobile connectivity capabilities. Medtronic had previously invested $20 million in Triple Jump and now plans to acquire the full holdings. The acquisition is expected to contribute to Medtronics growth in the medical devices market.
Acquisition
growth-positive
Medtronic investing $20 million in Israeli insulin pump startup Triple Jump
Medical device giant Medtronic has invested $20 million in Israeli startup Triple Jump, with the option to acquire the entire company. Triple Jump is developing a small insulin pump patch with mobile connectivity capabilities, which will be included in a future artificial pancreas system. Medtronic previously invested $4.5 million in BioProtect, an Israeli company developing a product to protect prostate cancer patients undergoing radiation therapy. Triple Jumps additional investors include Elixir Medical Corporation, Wealth Strategy Holding, and Dov Moran. Medtronic has previously acquired other Israeli companies, including Nutrino and Mazor Robotics.
Investment
